At Stendhal, we offer innovative solutions, products, and comprehensive services for the health and well-being of people. This approach has established us as experts in pharmaceutical distribution and logistics, and as leaders in the therapeutic areas in which we participate, with an innovative portfolio aimed at users with rare and chronic degenerative diseases, as well as the marketing of highly specialized medication. As a result, we have extended our coverage to almost 300 million inhabitants in the 14 countries of Latin America and the Caribbean in which we have a presence.

Derivado de lo anterior, hemos extendido nuestra cobertura a casi 300 millones de habitantes en los 14 países de América Latina y el Caribe en los que tenemos presencia: